Gusto Global
Daniel van der Lelie is a distinguished scientist and entrepreneur, serving as Chief Executive Officer and Chief Scientific Officer at Gusto Global LLC since 2016. A co-founder of the company, Daniel van der Lelie focuses on developing microbiome-based therapeutics and diagnostics to enhance clinical outcomes. Previously, Daniel van der Lelie held the position of Global Director of Biosolutions R&D at FMC Corporation, where efforts were directed towards sustainable agricultural biosolutions. Earlier at RTI International, Daniel van der Lelie founded the Center for Agricultural and Environmental Biotechnology, concentrating on sustainable agriculture and environmental applications. Daniel van der Lelie also served as a Senior Scientist at Brookhaven National Laboratory and as a Visiting Professor at Universiteit Hasselt. Daniel van der Lelie holds a PhD in Microbiology from the University of Groningen and an MBA from Vlerick Business School.
This person is not in any teams
This person is not in any offices
Gusto Global
Gusto Global is a biotechnology company that revolutionizes human health by building the discovery and development platform that applies ecological principles to restore key functionalities of a healthy microbiome. The company's platform integrates advanced computational and microbiological tools to discover and develop novel LiveBiotherapeutic Products (LBPs) with unprecedented speed and efficiency. Its ecological approach combines proprietary bioinformatics, AI, and microbiology expertise to identify differences in core microbiome functionalities between healthy and unhealthy individuals. Gusto's live biotherapeutics and companion diagnostics offer the potential for safer and more effective patient-centric care through disease prevention, early detection/diagnosis, intervention, and monitoring.Gusto Global was founded in 2015 and is headquartered in Charlotte, North Carolina.